Editorial: Government should explain plans in wake of J&J setback

Editorial: Government should explain plans in wake of J&J setback

Jabs from Johnson & Johnson were central to plans to scale up South Africa’s COVID-19 vaccination programme. With news that a first consignment of two million doses cannot be used, it is critical that government play open cards with the public about its revised vaccination plans and timelines and what steps it is taking to procure more vaccines faster.

Read More

COVID-19: A frontline view of vaccination efforts in the rural Eastern Cape

COVID-19: A frontline view of vaccination efforts in the rural Eastern Cape

By 13 June official statistics from the Department of Health showed 382 255 people 60 years and older in the Eastern Cape registered for COVID-19 vaccination. So far, 114 661 of them received their first dose of the Pfizer vaccine. Luvuyo Mehlwana visited some rural areas to see how registration and vaccination are going.

Read More

Hits and misses of the national vaccine rollout – experts weigh in

Hits and misses of the national vaccine rollout – experts weigh in

Government has been criticised for the slow pace of the country’s vaccine rollout which started on 17 May 2021. Elri Voigt spoke to experts to hear what is being done right in this vaccine rollout and where improvements are needed.

Read More

COVID-19: Numbers escalating in Free State schools

COVID-19: Numbers escalating in Free State schools

While it is uncertain when teachers in the Free State will receive vaccinations during this third wave, the number of COVID-19 infections and deaths in the province’s schools continues to increase. Refilwe Mochoari reports.

Read More

Trial of potentially variant-proof vaccine ongoing in Western Cape

Trial of potentially variant-proof vaccine ongoing in Western Cape

An experimental COVID-19 vaccine currently in Phase I trials being run by the University of Cape Town has a unique design that might allow it to offer better protection against current and future variants of the SARS-CoV-2 virus. Elri Voigt provides an update on the trial and unpacks the science behind this vaccine candidate.

Read More

Like a “blanket of fatigue” – Inside Groote Schuur’s long-COVID clinic

Like a “blanket of fatigue” – Inside Groote Schuur’s long-COVID clinic

As a third wave of COVID-19 looms in the Western Cape, a group of doctors at Groote Schuur Hospital’s Post-COVID-19 Lung Disease Clinic are treating patients who have recovered from COVID-19 but who suffer lingering symptoms such as fatigue and shortness of breath. Bienne Huisman paid them a visit.

Read More

COVID-19: What is the correct way to report vaccine-related adverse events?

COVID-19: What is the correct way to report vaccine-related adverse events?

Phase two of South Africa’s COVID-19 vaccine rollout is underway and members of the public are being asked to report any mild, moderate or severe adverse events experienced after receiving their jabs. Adele Baleta explains what the correct way is to report adverse events after vaccination.

Read More

In-depth: What will it take to actually make mRNA vaccines in SA

In-depth: What will it take to actually make mRNA vaccines in SA

Messenger RNA (mRNA) vaccines, such as the COVID-19 vaccines made by Moderna and Pfizer/BioNTech, have been hailed for their manufacturing advantages over conventional vaccines – so much so that African leaders such as President Cyril Ramaphosa has called for mRNA production capacity to be developed in Africa. Catherine Tomlinson examines why mRNA vaccines are easier to make than some other types of vaccines and asks what it will take to build such production capacity.

Read More

Western Cape to launch COVID-style tuberculosis dashboard

Western Cape to launch COVID-style tuberculosis dashboard

The COVID-19 pandemic caused huge setbacks for the fight against TB. Now, provinces are developing TB catch-up plans. The Western Cape Department of Health will soon launch a TB dashboard as part of its “multi-sectorial TB emergency response plan”. Tiyese Jeranji reports.

Read More

Analysis: We need to do for TB vaccines what we’ve done for COVID-19

Analysis: We need to do for TB vaccines what we’ve done for COVID-19

It is little wonder that some TB vaccine researchers suffer from a rare syndrome that understandably threatens their mental health. Symptoms include frustration, impatience, irritability, seemingly inexplicable rage, and in the least resilient, despair. It’s called VJS or vaccine jealousy syndrome, writes Chris Bateman.

Read More

COVID-19: What provinces have planned for older persons

COVID-19: What provinces have planned for older persons

Phase II of South Africa’s vaccination rollout has started. Elri Voigt unpacks how provinces will go about vaccinating those aged 60 and older.

Read More

1 2 3 25